Erythrocyte cAMP in Determining Frequency of Acute Pain Episodes in Sickle Cell Disease Patients from Odisha State, India

References

• Eaton WA, Hofrichter J. Hemoglobin S gelation and sickle cell disease. Blood. 1987;70(5):1245–1266.
   PubMed Web of Science ®Google Scholar
• Bunn H, Forget BG. Hemoglobin: Molecular, Genetic and Clinical Aspects. Philadelphia, PA, USA: WB Saunders; 1986.
   Google Scholar
• Steinberg MH. Pathophysiology of sickle cell disease. Bailliére’s Clin Haematol. 1998;11(1):163–184.
   PubMed Web of Science ®Google Scholar
• Kaul DK, Finnegan E, Barabino GA. Sickle red cell-endothelium interactions. Microcirculation. 2009;16(1):97–111.
   PubMed Web of Science ®Google Scholar
• Steinberg MH. Predicting clinical severity in sickle cell anaemia. Br J Haematol. 2005;129(4)465–481.
   PubMed Web of Science ®Google Scholar
• Telen MJ. Role of adhesion molecules and vascular endothelium in the pathogenesis of sickle cell disease. Hematology Am Soc Hematol Educ Program. 2007;84–90.
   PubMedGoogle Scholar
• Benovic JL. Novel β2-adrenergic receptor signaling pathways. J Allergy Clin Immunol. 2002;110(6):S229–S235.
   PubMedGoogle Scholar
• Eyler CE, Jackson T, Elliott LE, et al. β2-Adrenergic receptor and adenylate cyclase gene polymorphisms affect sickle red cell adhesion. Br J Haematol. 2008;141(1):105–108.
   PubMed Web of Science ®Google Scholar
• Benovic JL, Staniszewski C, Mayor F Jr, et al. β-Adrenergic receptor kinase. Activity of partial agonists for stimulation of adenylate cyclase correlates with ability to promote receptor phosphorylation. J Biol Chem. 1988;263(8):3893–3897.
   PubMed Web of Science ®Google Scholar
• Tuvia S, Moses A, Gulayev N, et al. β-Adrenergic agonists regulate cell membrane fluctuations of human erythrocytes. J Physiol. 1999;516(3):781–792.
   PubMed Web of Science ®Google Scholar
• Gilman AG. G proteins: transducers of receptorgenerated signals. Annu Rev Biochem. 1987;56:615–649.
   PubMed Web of Science ®Google Scholar
• Brittain JE, Mlinar KJ, Anderson CS, et al. Activation of sickle red blood cell adhesion via integrin-associated protein/CD47-induced signal transduction. J Clin Invest. 2001;107(12):1555–1562.
   PubMed Web of Science ®Google Scholar
• Hines PC, Zen Q, Burney SN, et al. Novel epinephrine and cyclic AMP-mediated activation of BCAM/Lu-dependent sickle (SS) RBC adhesion. Blood. 2003;101(8):3281–3287.
   PubMed Web of Science ®Google Scholar
• Bartolucci P, Chaar V, Picot J, et al. Decreased sickle red blood cell adhesion to laminin by hydroxyurea is associated with inhibition of Lu/BCAM protein phosphorylation. Blood. 2010;116(12):2152–2159.
   PubMed Web of Science ®Google Scholar
• Chaar V, Laurance S, Lapoumeroulie C, et al. Hydroxycarbamide decreases sickle reticulocyte adhesion to resting endothelium by inhibiting endothelial Lutheran/Basal Cell Adhesion Molecule (Lu/BCAM) through phosphodiesterase 4A activation. J Biol Chem. 2014;289(16):11512–11521.
   PubMed Web of Science ®Google Scholar
• Maciaszek JL, Andemariam B, Abiraman K, Lykotrafitis G. AKAP-dependent modulation of BCAM/Lu adhesion on normal and sickle cell disease rbcs revealed by force nanoscopy. Biophys J. 2014;106(6):1258–1267.
   PubMed Web of Science ®Google Scholar
• Zennadi R, Hines PC, De Castro LM, et al. Epinephrine acts through erythroid signaling pathways to activate sickle cell adhesion to endothelium via LW-alphavbeta3 interactions. Blood. 2004;104(12):3774–3781.
   PubMed Web of Science ®Google Scholar
• Zennadi R, Moeller BJ, Whalen EJ, et al. Epinephrine-induced activation of LW-mediated sickle cell adhesion and vaso-occlusion in vivo. Blood. 2007;110(7):2708–2717.
   PubMed Web of Science ®Google Scholar
• Brittain JE, Han J, Ataga KI, et al. Mechanism of CD47-induced α4β1 integrin activation and adhesion in sickle reticulocytes. J Biol Chem. 2004;279(41):42393–42402.
   PubMed Web of Science ®Google Scholar
• Mohanty D, Mukherjee MB. Sickle cell disease in India. Curr Opin Hematol. 2002;9(2):117–122.
   PubMed Web of Science ®Google Scholar
• Purohit P, Dehury S, Patel S, Patel DK. Prevalence of deletional α thalassemia and sickle gene in a tribal dominated malaria endemic area of eastern India. ISRN Hematol. 2014;2014:745245. eCollection 2014.
   PubMedGoogle Scholar
• Miller BA, Olivieri N, Salameh M, et al. Molecular analysis of the high-Hemoglobin-F phenotype in Saudi Arabian sickle-cell anemia. N Engl J Med. 1987;316(5):244–250.
   PubMed Web of Science ®Google Scholar
• Jit BP, Mohanty PK, Purohit P, et al. Association of fetal hemoglobin level with frequency of acute pain episodes in sickle cell disease (Hb S-only phenotype) patients. Blood Cells Mol Dis. 2019;75:30–34.
   PubMed Web of Science ®Google Scholar
• Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease, rates and risk factors. N Engl J Med. 1991;325(1):11–16.
   PubMed Web of Science ®Google Scholar
• Habara AH, Shaikho EM, Steinberg MH. Fetal hemoglobin in sickle cell anemia: the Arab-Indian haplotype and new therapeutic agents. Am J Hematol. 2017;92(11):1233–1242.
   PubMed Web of Science ®Google Scholar
• Old JM, Higgs DR. Gene analysis. In: Weatherall DJ, Editor. The Thalassaemias Methods in Hematology. Edinburgh (Scotland, UK): Churchill Livingstone. 1982:74–102.
   Google Scholar
• Chong SS, Boehm CD, Higgs DR, Cutting GR. Single-tube multiplex-PCR screen for common deletional determinants of α thalassemia. Blood. 2000;95(1):360–362.
   PubMed Web of Science ®Google Scholar
• Bain BJ, Bates I, Laffan MA, Lewis SM. Dacie and Lewis Practical Haematology, 12th ed. Amsterdam (The Netherlands): Elsevier, 2016 (Paperback ISBN: 9780702066962).
   Google Scholar
• Rajagopal S, Rajagopal K, Lefkowitz RJ. Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nat Rev Drug Discov. 2010;9(5):373–386.
   PubMed Web of Science ®Google Scholar
• Whalen EJ, Rajagopal S, Lefkowitz RJ. Therapeutic potential of β-arrestin- and G protein-biased agonists. Trends Mol Med. 2011;17(3):126–139.
   PubMed Web of Science ®Google Scholar
• Akinbami A, Dosunmu A, Adediran A, et al. Haematological values in homozygous sickle cell disease in steady state and haemoglobin phenotypes AA controls in Lagos, Nigeria. BMC Res Notes. 2012;5:396.
   PubMedGoogle Scholar
• Curtis SA, Danda N, Etzion Z, et al. Elevated steady state WBC and platelet counts are associated with frequent emergency room use in adults with sickle cell anemia. PLoS One. 2015;10(8):e0133116.
   PubMed Web of Science ®Google Scholar
• Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994;330(23):1639–1644.
   PubMed Web of Science ®Google Scholar
• Cartron JP, Elion J. Erythroid adhesion molecules in sickle cell disease: effect of hydroxyurea. Transfus Clin Biol. 2008;15(1-2):39–50.
   PubMed Web of Science ®Google Scholar